1. Cavill I, Auerbach M, Bailie GR, Barrett-Lee P, Beguin Y, Wilson K, et al. Iron and the anaemia of chronic disease: a review and strategic recommendations. Curr Med Res Opin 2006;22:731-737.
2. Thomas C, Kirschbaum A, Boehm D, Thomas L. The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy. Med Oncol 2006;23:23-36.
3. Ganz T. Molecular pathogenesis of anemia of chronic disease. Pediatr Blood Cancer 2006;46:554-557.
4. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-1023.
5. Korean Society of Hematology. Hematology 2006;1st ed. E-Public. 68-71.
6. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345:1230-1236.
7. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Peres-Bota D, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002;288:1499-1507.
8. Weiss G, Gordeuk VR. Benefits and risks of iron therapy for chronic anaemias. Eur J Clin Invest 2005;35:Suppl 3. 36-45.
9. Nissenson AR, Swan SK, Lindberg JS, Soroka SD, Beatey R, Maroni BJ, et al. Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients. Am J Kidney Dis 2002;07. 40:110-118.
10. Kaltwasser JP, Kessler U, Gottschalk R, Stucki G, Moller B. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J Rheumatol 2001;28:2430-2436.
11. Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G. Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin. Kidney Int 2003;64:572-578.
12. Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Soubeyran P, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer 2004;40:2201-2216.